Imunon
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$19,514,977 over the previous period. Total operating expenses were $21,030,430.

Profit Margin

Imunon, Inc. (NASDAQ:CLSN): Profit margin
2014 500K -25.49M -5098.85%
2015 500K -22.46M -4492.22%
2016 500K -22.05M -4410.8%
2017 500K -20.40M -4080.44%
2018 500K -11.88M -2376.67%
2019 500K -16.85M -3370.31%
2020 500K -21.48M -4296.71%
2021 500K -20.76M -4153.8%
2022 500K -35.89M -7179.6%
2023 0 -19.51M

CLSN Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0500K500K500K500K500K500K500K500K500K
Cost of revenue
720.00K731.62K702.91K11.34M13.06M013.07M000
Gross profit
-720.00K-231.62K-202.91K-10.84M-12.56M500K-12.57M500K500K500K
Operating exp.
Research and development
11.28M11.73M10.61M11.34M13.06M11.86M13.07M14.62M14.65M14.96M
Selling and marketing
0000000000
Total operating expenses
21.03M25.42M21.50M18.98M21.06M21.56M18.96M21.15M21.34M23.82M
Operating income
-21.03M-24.92M-21.00M-18.48M-20.56M-21.06M-18.46M-20.65M-20.84M-24.71M
Other income (expenses), net
235.06K-12.54M-1.14M-4.84M1.89M-857.18K-1.93M-711K-1.61M-779.07K
Income before tax
-20.79M-37.46M-22.15M-23.32M-18.66M-22.30M-20.40M-22.05M-22.46M-25.49M
Income tax expense
-1.28M-1.56M-1.38M-1.84M-1.81M-10.41M1.93M1.40M1.61M779.07K
Net income
-19.51M-35.89M-20.76M-21.48M-16.85M-11.88M-20.40M-22.05M-22.46M-25.49M
Earnings per share
Basic EPS
-2.16-5.03-57.41-10.08-11.58-10.14-40.12-178.42-216.24-289.83
Diluted EPS
-2.16-5.03-57.41-10.08-11.58-10.14-40.12-178.42-216.24-289.83
Data sourceData source